NCT01398904

Brief Summary

Body Dysmorphic Disorder (BDD) participants will demonstrate greater attentional biases as compared to healthy control (HC) participants. Greater attention bias will be associated with greater distress. Greater attention bias will be associated with greater symptom severity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
51

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Mar 2011

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2011

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

July 15, 2011

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 21, 2011

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2012

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2012

Completed
Last Updated

December 3, 2014

Status Verified

December 1, 2014

Enrollment Period

1.3 years

First QC Date

July 15, 2011

Last Update Submit

December 2, 2014

Conditions

Keywords

BDD

Outcome Measures

Primary Outcomes (1)

  • Attention Pattern

    Gaze tracking via an Eyelink II eye tracker will determine perception of visual information.

    Day 2

Secondary Outcomes (2)

  • Subjective Units of Distress Scale (SUDS)

    Day 2

  • Facial Attractiveness

    Day 2

Study Arms (2)

Body dysmorphic disorder (BDD) Participants

Participants must be 18 years or older with a primary diagnosis of body dysmorphic disorder (BDD), a BDD Yale-Brown Obsessive Compulsive Scale (BDDY-BOCS) score of \>20, and a primary facial/head concern. Participants must have the ability to provide informed consent and understand study staff.

Healthy Controls

Males and females 18 years of age or older with ability to provide informed consent and understand study staff.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

The study will include 40 participants, consisting of 20 BDD participants and 20 matched healthy controls.

You may qualify if:

  • males and females 18 years of age or older
  • sufficient fluency of English to understand study staff, procedures, and questionnaires
  • ability to provide informed consent
  • primary diagnosis of Diagnostic and Statistical Manual 4th Edition (DSM-IV-TR) BDD
  • BDD Yale-Brown Obsessive Compulsive Disorder score (Y-BOCS) of \> 20
  • primary facial/head concern

You may not qualify if:

  • Major medical or neurological conditions
  • schizophrenia, schizoaffective disorder, or any other current lifetime DSM-IV psychotic disorder that is not attributable to delusional BDD
  • current suicidality
  • current homicidality
  • Any current Axis I psychiatric illness
  • history of BDD

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Massachusetts General Hospital

Boston, Massachusetts, 02114, United States

Location

Related Publications (10)

  • Deckersbach T, Savage CR, Phillips KA, Wilhelm S, Buhlmann U, Rauch SL, Baer L, Jenike MA. Characteristics of memory dysfunction in body dysmorphic disorder. J Int Neuropsychol Soc. 2000 Sep;6(6):673-81. doi: 10.1017/s1355617700666055.

    PMID: 11011514BACKGROUND
  • Phillips KA. Quality of life for patients with body dysmorphic disorder. J Nerv Ment Dis. 2000 Mar;188(3):170-5. doi: 10.1097/00005053-200003000-00007.

    PMID: 10749282BACKGROUND
  • Phillips KA, Coles ME, Menard W, Yen S, Fay C, Weisberg RB. Suicidal ideation and suicide attempts in body dysmorphic disorder. J Clin Psychiatry. 2005 Jun;66(6):717-25. doi: 10.4088/jcp.v66n0607.

    PMID: 15960564BACKGROUND
  • Phillips KA, Menard W, Fay C, Pagano ME. Psychosocial functioning and quality of life in body dysmorphic disorder. Compr Psychiatry. 2005 Jul-Aug;46(4):254-60. doi: 10.1016/j.comppsych.2004.10.004.

    PMID: 16175755BACKGROUND
  • Savage CR, Baer L, Keuthen NJ, Brown HD, Rauch SL, Jenike MA. Organizational strategies mediate nonverbal memory impairment in obsessive-compulsive disorder. Biol Psychiatry. 1999 Apr 1;45(7):905-16. doi: 10.1016/s0006-3223(98)00278-9.

    PMID: 10202579BACKGROUND
  • Kelly MM, Walters C, Phillips KA. Social anxiety and its relationship to functional impairment in body dysmorphic disorder. Behav Ther. 2010 Jun;41(2):143-53. doi: 10.1016/j.beth.2009.01.005. Epub 2009 Oct 7.

    PMID: 20412881BACKGROUND
  • Maner JK, Holm-Denoma JM, Van Orden KA, Gailliot MT, Gordon KH, Joiner TE Jr. Evidence for attentional bias in women exhibiting bulimotypic symptoms. Int J Eat Disord. 2006 Jan;39(1):55-61. doi: 10.1002/eat.20222.

    PMID: 16231350BACKGROUND
  • Roefs A, Jansen A, Moresi S, Willems P, van Grootel S, van der Borgh A. Looking good. BMI, attractiveness bias and visual attention. Appetite. 2008 Nov;51(3):552-5. doi: 10.1016/j.appet.2008.04.008. Epub 2008 Apr 15.

    PMID: 18495295BACKGROUND
  • Carey P, Seedat S, Warwick J, van Heerden B, Stein DJ. SPECT imaging of body dysmorphic disorder. J Neuropsychiatry Clin Neurosci. 2004 Summer;16(3):357-9. doi: 10.1176/jnp.16.3.357.

    PMID: 15377744BACKGROUND
  • Janelle CM, Hausenblas HA, Fallon EA, Gardner RE. A visual search examination of attentional biases among individuals with high and low drive for thinness. Eat Weight Disord. 2003 Jun;8(2):138-44. doi: 10.1007/BF03325003.

    PMID: 12880191BACKGROUND

MeSH Terms

Conditions

Body Dysmorphic Disorders

Condition Hierarchy (Ancestors)

Somatoform DisordersMental Disorders

Study Officials

  • Sabine Wilhelm, Ph. D.

    Massachusetts General Hospital

    PRINCIPAL INVESTIGATOR
  • Jennifer Greenberg, Psy. D.

    Massachusetts General Hospital

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director, OCD & Related Disorders Program

Study Record Dates

First Submitted

July 15, 2011

First Posted

July 21, 2011

Study Start

March 1, 2011

Primary Completion

July 1, 2012

Study Completion

July 1, 2012

Last Updated

December 3, 2014

Record last verified: 2014-12

Locations